Ayyappan Anitha1, Ismail Thanseem2, Kazuhiko Nakamura3, Mahesh M Vasu2, Kazuo Yamada4, Takatoshi Ueki5, Yoshimi Iwayama4, Tomoko Toyota4, Kenji J Tsuchiya1, Yasuhide Iwata2, Katsuaki Suzuki2, Toshiro Sugiyama6, Masatsugu Tsujii7, Takeo Yoshikawa4, Norio Mori8. 1. Research Center for Child Mental Development, Hamamatsu University School of Medicine, Hamamatsu, Japan. 2. Department of Psychiatry, Hamamatsu University School of Medicine, Hamamatsu, Japan. 3. Department of Psychiatry, Hirosaki University School of Medicine, Hirosaki, Japan. 4. Laboratory for Molecular Psychiatry, RIKEN Brain Science Institute, Wako, Japan. 5. Department of Anatomy, Hamamatsu University School of Medicine, Hamamatsu, Japan. 6. Department of Child and Adolescent Psychiatry, Hamamatsu University School of Medicine, Hamamatsu, Japan. 7. Research Center for Child Mental Development, Hamamatsu University School of Medicine, Hamamatsu, Japan; Faculty of Sociology, Chukyo University, Toyota, Japan. 8. Research Center for Child Mental Development, Hamamatsu University School of Medicine, Hamamatsu, Japan; Department of Psychiatry, Hamamatsu University School of Medicine, Hamamatsu, Japan.
Abstract
BACKGROUND: In a genome-wide association study of autism, zinc finger protein 804A (ZNF804A) single nucleotide polymorphisms (SNPs) were found to be nominally associated in verbally deficient individuals with autism. Zinc finger protein 804A copy number variations (CNVs) have also been observed in individuals with autism. In addition, ZNF804A is known to be involved in theory of mind (ToM) tasks, and ToM deficits are deemed responsible for the communication and social challenges faced by individuals with autism. We hypothesized that ZNF804A could be a risk gene for autism. METHODS: We examined the genetic association and CNVs of ZNF804A in 841 families in which 1 or more members had autism. We compared the expression of ZNF804A in the postmortem brains of individuals with autism (n = 8) and controls (n = 13). We also assessed in vitro the effect of ZNF804A silencing on the expression of several genes known to be involved in verbal efficiency and social cognition. RESULTS: We found that rs7603001 was nominally associated with autism (p = 0.018). The association was stronger (p = 0.008) in the families of individuals with autism who were verbally deficient (n = 761 families). We observed ZNF804A CNVs in 7 verbally deficient boys with autism. In ZNF804A knockdown cells, the expression of synaptosomal-associated protein, 25kDa (SNAP25) was reduced compared with controls (p = 0.009). The expression of ZNF804A (p = 0.009) and SNAP25 (p = 0.009) were reduced in the anterior cingulate gyrus (ACG) of individuals with autism. There was a strong positive correlation between the expression of ZNF804A and SNAP25 in the ACG (p < 0.001). LIMITATIONS: Study limitations include our small sample size of postmortem brains. CONCLUSION: Our results suggest that ZNF804A could be a potential candidate gene mediating the intermediate phenotypes associated with verbal traits in individuals with autism.
BACKGROUND: In a genome-wide association study of autism, zinc finger protein 804A (ZNF804A) single nucleotide polymorphisms (SNPs) were found to be nominally associated in verbally deficient individuals with autism. Zinc finger protein 804A copy number variations (CNVs) have also been observed in individuals with autism. In addition, ZNF804A is known to be involved in theory of mind (ToM) tasks, and ToM deficits are deemed responsible for the communication and social challenges faced by individuals with autism. We hypothesized that ZNF804A could be a risk gene for autism. METHODS: We examined the genetic association and CNVs of ZNF804A in 841 families in which 1 or more members had autism. We compared the expression of ZNF804A in the postmortem brains of individuals with autism (n = 8) and controls (n = 13). We also assessed in vitro the effect of ZNF804A silencing on the expression of several genes known to be involved in verbal efficiency and social cognition. RESULTS: We found that rs7603001 was nominally associated with autism (p = 0.018). The association was stronger (p = 0.008) in the families of individuals with autism who were verbally deficient (n = 761 families). We observed ZNF804A CNVs in 7 verbally deficient boys with autism. In ZNF804A knockdown cells, the expression of synaptosomal-associated protein, 25kDa (SNAP25) was reduced compared with controls (p = 0.009). The expression of ZNF804A (p = 0.009) and SNAP25 (p = 0.009) were reduced in the anterior cingulate gyrus (ACG) of individuals with autism. There was a strong positive correlation between the expression of ZNF804A and SNAP25 in the ACG (p < 0.001). LIMITATIONS: Study limitations include our small sample size of postmortem brains. CONCLUSION: Our results suggest that ZNF804A could be a potential candidate gene mediating the intermediate phenotypes associated with verbal traits in individuals with autism.
Authors: Danielle Posthuma; Michelle Luciano; Eco J C de Geus; Margie J Wright; P Eline Slagboom; Grant W Montgomery; Dorret I Boomsma; Nicholas G Martin Journal: Am J Hum Genet Date: 2005-07-01 Impact factor: 11.025
Authors: Michael C O'Donovan; Nicholas Craddock; Nadine Norton; Hywel Williams; Timothy Peirce; Valentina Moskvina; Ivan Nikolov; Marian Hamshere; Liam Carroll; Lyudmila Georgieva; Sarah Dwyer; Peter Holmans; Jonathan L Marchini; Chris C A Spencer; Bryan Howie; Hin-Tak Leung; Annette M Hartmann; Hans-Jürgen Möller; Derek W Morris; Yongyong Shi; GuoYin Feng; Per Hoffmann; Peter Propping; Catalina Vasilescu; Wolfgang Maier; Marcella Rietschel; Stanley Zammit; Johannes Schumacher; Emma M Quinn; Thomas G Schulze; Nigel M Williams; Ina Giegling; Nakao Iwata; Masashi Ikeda; Ariel Darvasi; Sagiv Shifman; Lin He; Jubao Duan; Alan R Sanders; Douglas F Levinson; Pablo V Gejman; Sven Cichon; Markus M Nöthen; Michael Gill; Aiden Corvin; Dan Rujescu; George Kirov; Michael J Owen; Nancy G Buccola; Bryan J Mowry; Robert Freedman; Farooq Amin; Donald W Black; Jeremy M Silverman; William F Byerley; C Robert Cloninger Journal: Nat Genet Date: 2008-09 Impact factor: 38.330
Authors: H J Williams; N Norton; S Dwyer; V Moskvina; I Nikolov; L Carroll; L Georgieva; N M Williams; D W Morris; E M Quinn; I Giegling; M Ikeda; J Wood; T Lencz; C Hultman; P Lichtenstein; D Thiselton; B S Maher; A K Malhotra; B Riley; K S Kendler; M Gill; P Sullivan; P Sklar; S Purcell; V L Nimgaonkar; G Kirov; P Holmans; A Corvin; D Rujescu; N Craddock; M J Owen; M C O'Donovan Journal: Mol Psychiatry Date: 2010-04-06 Impact factor: 15.992
Authors: David E J Linden; Thomas M Lancaster; Claudia Wolf; Alison Baird; Margaret C Jackson; Stephen J Johnston; Rossen Donev; Johannes Thome Journal: Neuropsychobiology Date: 2013-01-04 Impact factor: 2.328
Authors: P J Michael Deans; Pooja Raval; Katherine J Sellers; Nicholas J F Gatford; Sanjay Halai; Rodrigo R R Duarte; Carole Shum; Katherine Warre-Cornish; Victoria E Kaplun; Graham Cocks; Matthew Hill; Nicholas J Bray; Jack Price; Deepak P Srivastava Journal: Biol Psychiatry Date: 2016-09-15 Impact factor: 13.382
Authors: Ria M Chapman; Caroline L Tinsley; Matthew J Hill; Marc P Forrest; Katherine E Tansey; Antonio F Pardiñas; Elliott Rees; A Michelle Doyle; Lawrence S Wilkinson; Michael J Owen; Michael C O'Donovan; Derek J Blake Journal: Schizophr Bull Date: 2019-10-24 Impact factor: 9.306